Dihexa (PNB-0408) | c-Met/HGFR Activator
US$ 22.58
crohn's disease and glutathione Inflammatory bowel (IBD) locus 12: is peroxidase-1 (GPX1) the relevant gene? Colitis/Crohn's Disease– Page 3 |
Description
No published human clinical trials of Dihexa itself had reported as of 2026
USE OF THIS SYSTEM CONSTITUTES CONSENT TO MONITORING FOR THESE PURPOSES
This regulatory situation creates challenges
IV (weekly): 250 mg/week or 500 mg/week , depending on the infusion length/volume
